Market Share of North America Clinical Trials Industry
The North America Clinical Trials Market is fragmented competitive and consists of several major players. The major pharmaceutical companies are found making enormous investments in R&D, especially in the emerging nations, in order to gain opportunities for market growth in the major regions. The strategic partnerships among pharmaceutical companies and the CROs are expected to have a significant impact on the market's growth.
North America Clinical Trials Market Leaders
-
Novo Nordisk AS
-
ICON Plc
-
Eli Lilly and Company
-
IQVIA
-
Clinipace
*Disclaimer: Major Players sorted in no particular order
